Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Medico Remedies is engaged in the manufacturing of allopathic pharmaceutical preparations
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Pursuant to Circular CIR/CFD/CMD1/27/2019 dated February 08, 2019 for the purpose ofcompliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find enclosed herewith the Annual Secretarial Compliance Report forthe year ended 31st March, 2023. | Download
Pursuant to Circular CIR/CFD/CMD1/27/2019 dated February 08, 2019 for the purpose ofcompliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find enclosed herewith the Annual Secretarial Compliance Report forthe year ended 31st March, 2023. | Download
Medico Remedies Limited has informed the Exchange regarding 'Machine readabale and searchable copy of the financials for the period ended 31st March, 2023'. | Download
Medico Remedies Limited has informed the Exchange regarding 'Machine readabale and searchable copy of the financials for the period ended 31st March, 2023'. | Download
Medico Remedies Limited has informed the Exchange regarding a press release dated May 13, 2023, titled "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed herewith Press Release about, "Medico Remedies Limited is pleased to announce its readiness to foray into ointment manufacturing segment'.". | Download
Medico Remedies Limited has informed the Exchange regarding a press release dated May 13, 2023, titled "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed herewith Press Release about, "Medico Remedies Limited is pleased to announce its readiness to foray into ointment manufacturing segment'.". | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant